141 related articles for article (PubMed ID: 36288278)
1. Therapeutic gene editing of T cells to correct CTLA-4 insufficiency.
Fox TA; Houghton BC; Petersone L; Waters E; Edner NM; McKenna A; Preham O; Hinze C; Williams C; de Albuquerque AS; Kennedy A; Pesenacker AM; Genovese P; Walker LSK; Burns SO; Sansom DM; Booth C; Morris EC
Sci Transl Med; 2022 Oct; 14(668):eabn5811. PubMed ID: 36288278
[TBL] [Abstract][Full Text] [Related]
2. Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.
Kennedy A; Waters E; Rowshanravan B; Hinze C; Williams C; Janman D; Fox TA; Booth C; Pesenacker AM; Halliday N; Soskic B; Kaur S; Qureshi OS; Morris EC; Ikemizu S; Paluch C; Huo J; Davis SJ; Boucrot E; Walker LSK; Sansom DM
Nat Immunol; 2022 Sep; 23(9):1365-1378. PubMed ID: 35999394
[TBL] [Abstract][Full Text] [Related]
3. CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.
Kurtz J; Raval F; Vallot C; Der J; Sykes M
Blood; 2009 Apr; 113(15):3475-84. PubMed ID: 19179471
[TBL] [Abstract][Full Text] [Related]
4. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
5. Intracellular concentrations of Ca(2+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-CD80/CD86 interactions in CD4(+) T lymphocytes.
Ahmed A; Mukherjee S; Nandi D
Immunology; 2009 Mar; 126(3):363-77. PubMed ID: 18710402
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Analysis of CTLA-4-Mediated Transendocytosis by Regulatory T Cells.
Waters E; Williams C; Kennedy A; Sansom DM
Methods Mol Biol; 2023; 2559():171-187. PubMed ID: 36180633
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 differentially regulates the immunological synapse in CD4 T cell subsets.
Jackman RP; Balamuth F; Bottomly K
J Immunol; 2007 May; 178(9):5543-51. PubMed ID: 17442936
[TBL] [Abstract][Full Text] [Related]
8. By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
Kleinpeter P; Remy-Ziller C; Winter E; Gantzer M; Nourtier V; Kempf J; Hortelano J; Schmitt D; Schultz H; Geist M; Brua C; Hoffmann C; Schlesinger Y; Villeval D; Thioudellet C; Erbs P; Foloppe J; Silvestre N; Fend L; Quemeneur E; Marchand JB
J Virol; 2019 Jun; 93(11):. PubMed ID: 30918073
[TBL] [Abstract][Full Text] [Related]
9. Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells.
Lorenzetti R; Janowska I; Smulski CR; Frede N; Henneberger N; Walter L; Schleyer MT; Hüppe JM; Staniek J; Salzer U; Venhoff A; Troilo A; Voll RE; Venhoff N; Thiel J; Rizzi M
J Autoimmun; 2019 Jul; 101():145-152. PubMed ID: 31054942
[TBL] [Abstract][Full Text] [Related]
10. Preferential costimulation by CD80 results in IL-10-dependent TGF-beta1(+) -adaptive regulatory T cell generation.
Perez N; Karumuthil-Melethil S; Li R; Prabhakar BS; Holterman MJ; Vasu C
J Immunol; 2008 May; 180(10):6566-76. PubMed ID: 18453575
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Cytotoxic T-Lymphocyte-Associated Antigen-4 Prevents Atherosclerosis in Mice.
Matsumoto T; Sasaki N; Yamashita T; Emoto T; Kasahara K; Mizoguchi T; Hayashi T; Yodoi K; Kitano N; Saito T; Yamaguchi T; Hirata K
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1141-51. PubMed ID: 27055906
[TBL] [Abstract][Full Text] [Related]
12. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.
Loser K; Scherer A; Krummen MB; Varga G; Higuchi T; Schwarz T; Sharpe AH; Grabbe S; Bluestone JA; Beissert S
J Immunol; 2005 May; 174(9):5298-305. PubMed ID: 15843526
[TBL] [Abstract][Full Text] [Related]
13. CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis.
Soskic B; Jeffery LE; Kennedy A; Gardner DH; Hou TZ; Halliday N; Williams C; Janman D; Rowshanravan B; Hirschfield GM; Sansom DM
Front Immunol; 2020; 11():577655. PubMed ID: 33488578
[TBL] [Abstract][Full Text] [Related]
14. Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia.
LaBelle JL; Hanke CA; Blazar BR; Truitt RL
Blood; 2002 Mar; 99(6):2146-53. PubMed ID: 11877291
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function.
Jeffery LE; Qureshi OS; Gardner D; Hou TZ; Briggs Z; Soskic B; Baker J; Raza K; Sansom DM
PLoS One; 2015; 10(7):e0131539. PubMed ID: 26134669
[TBL] [Abstract][Full Text] [Related]
16. B7-independent inhibition of T cells by CTLA-4.
Chikuma S; Abbas AK; Bluestone JA
J Immunol; 2005 Jul; 175(1):177-81. PubMed ID: 15972645
[TBL] [Abstract][Full Text] [Related]
17. A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells.
Hou TZ; Qureshi OS; Wang CJ; Baker J; Young SP; Walker LS; Sansom DM
J Immunol; 2015 Mar; 194(5):2148-59. PubMed ID: 25632005
[TBL] [Abstract][Full Text] [Related]
18. Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation.
Darlington PJ; Kirchhof MG; Criado G; Sondhi J; Madrenas J
J Immunol; 2005 Jul; 175(2):996-1004. PubMed ID: 16002699
[TBL] [Abstract][Full Text] [Related]
19. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
[TBL] [Abstract][Full Text] [Related]
20. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
